Detection of propionic acidemia, fatty acid metabolism disorders, Fabry disease and mitochondrial disease in patients with hypertrophic cardiomyopathy / dilated cardiomyopathy

High-risk screening for propionic acidemia, fatty acid metabolism disorders, Fabry disease and mitochondrial disease in patients with hypertrophic cardiomyopathy / dilated cardiomyopathy - High-risk screening for metabolic disorders in patients with hypertrophic cardiomyopathy and dilated cardiomyopathy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047347

Enrollment

300

Registered

2022-03-31

Start date

2021-03-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertrophic cardiomyopathy / dilated cardiomyopathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with hypertrophic cardiomyopathy or dilated cardiomyopathy of unknown cause

Exclusion criteria

Exclusion criteria: Patients with hypertrophic cardiomyopathy or dilated cardiomyopathy whose etiology is already clear

Design outcomes

Primary

Measure	Time frame
Prevalence of propionic acidemia, fatty acid metabolism disorders, Fabry disease, mitochondrial disease	—

Secondary

Measure	Time frame
search for clinical characteristics of metabolic disorders	—

Countries

Japan

Contacts

Public ContactTakahisa Noma

Kagawa university Faculty of medicine, Department of cardiorenal cerebrovascular medicine

noma.takahisa.ps@kagawa-u.ac.jp087-891-2150

Outcome results